These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Skalpe IO, Tang GJ. Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126 [Abstract] [Full Text] [Related]
5. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs. Peters JL, Shaw DD. Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191 [Abstract] [Full Text] [Related]
6. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats. Mühler A, Saeed M, Brasch RC, Higgins CB. Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362 [Abstract] [Full Text] [Related]
7. Cardiovascular responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction. Li HT, Saeed M, Wendland MF, Higgins CB. Invest Radiol; 1993 Jan; 28(1):11-9. PubMed ID: 8425847 [Abstract] [Full Text] [Related]
8. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance]. Campos A, Aznar L, Alamar R, Castelló JV. Med Clin (Barc); 1996 Feb 10; 106(5):197. PubMed ID: 8684023 [No Abstract] [Full Text] [Related]
9. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Heinrich MC, Kuhlmann MK, Kohlbacher S, Scheer M, Grgic A, Heckmann MB, Uder M. Radiology; 2007 Feb 10; 242(2):425-34. PubMed ID: 17179401 [Abstract] [Full Text] [Related]
15. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats. Masui T, Takehara Y, Aoshima R, Kaneko M. Invest Radiol; 1994 Jun 10; 29 Suppl 2():S189-91. PubMed ID: 7928226 [No Abstract] [Full Text] [Related]
16. Clinical safety of gadopentetate dimeglumine. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Radiology; 1995 Aug 10; 196(2):439-43. PubMed ID: 7617858 [Abstract] [Full Text] [Related]
17. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients. Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ. Comput Med Imaging Graph; 1994 Aug 10; 18(5):391-9. PubMed ID: 7954317 [Abstract] [Full Text] [Related]